ACN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q3

FY2026Q4

17.79B

+6.78%

2.857

+1.32%

18.69B

+5.45%

3.694

+5.85%

18.55B

+5.42%

3.347

+10.47%

Estimates Revision

The market is revising Upward the revenue expectations for Accenture plc (ACN) for FY2026, with the revenue forecasts being adjusted by 0.13% over the past three months. During the same period, the stock price has changed by 11.40%.

Revenue Estimates for FY2026

Revise Upward

+0.13%

In Past 3 Month

EPS Estimates for FY2026

Revise Downward

-0.07%

In Past 3 Month

Stock Price

Go Up

+11.40%

In Past 3 Month

21 Analyst Rating

Wall Street analysts forecast ACN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACN is 287.65 USD with a low forecast of 250.00 USD and a high forecast of 346.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

12 Buy

9 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

250.00

Averages

287.65

High

346.00

Current: 0.000

Low

250.00

Averages

287.65

High

346.00

Baird

Eric Coldwell

Outperform

downgrade

$7 -> $5

2026-01-06

New

Reason

Baird

Eric Coldwell

Price Target

$7 -> $5

2026-01-06

New

downgrade

Outperform

Reason

Baird analyst Eric Coldwell lowered the firm's price target on Accendra Health to $5 from $7 and keeps an Outperform rating on the shares. The firm updated its model following the closing of the sale of PHS and its rebranding from Owens & Minor to Accendra Health.

Truist

initiated

$317

2026-01-06

New

Reason

Truist

Price Target

$317

2026-01-06

New

initiated

Reason

Truist initiated coverage of Accenture with a Buy rating and $317 price target. Accenture provides a relatively attractive, though not risk-free, way to gain exposure to enterprise modernization driven by GenAI, offering mid-single-digit growth and stable margins at a reasonable valuation that is discounted versus its history, the analyst tells investors in a research note. Despite near-term cannibalization concerns, strategic partnerships and a strong track record of adapting legacy revenue position patient investors for potential upside, the firm says.

BofA

Underperform

downgrade

2026-01-05

New

Reason

BofA

Price Target

2026-01-05

New

downgrade

Underperform

Reason

BofA lowered the firm's price target on Accendra Health to $2.50 from $4.70 and keeps an Underperform rating on the shares. Heading into 2026, the firm maintains its positive view on the drug distributor group and updates its price targets to reflect peer group multiple changes.

UBS

Kevin McVeigh

Buy

maintain

$315 -> $320

2025-12-19

Reason

UBS

Kevin McVeigh

Price Target

$315 -> $320

2025-12-19

maintain

Buy

Reason

UBS analyst Kevin McVeigh raised the firm's price target on Accenture to $320 from $315 and keeps a Buy rating on the shares.

Susquehanna

Neutral

maintain

$270 -> $277

2025-12-19

Reason

Susquehanna

Price Target

$270 -> $277

2025-12-19

maintain

Neutral

Reason

Susquehanna raised the firm's price target on Accenture to $277 from $270 and keeps a Neutral rating on the shares. The firm said despite landing towards the high end of guidance, the outlook remained largely unchanged, and the Book/Bill supports the outlook.

RBC Capital

Outperform

maintain

$285 -> $295

2025-12-19

Reason

RBC Capital

Price Target

$285 -> $295

2025-12-19

maintain

Outperform

Reason

RBC Capital raised the firm's price target on Accenture to $295 from $285 and keeps an Outperform rating on the shares after its Q1 earnings beat. The company delivered a solid quarter beating estimates, with overall bookings up 10% y/y in local currency and AI bookings up about 22% from Q4, the analyst tells investors in a research note. The firm is also slightly increasing its price target to reflect Accenture's increasingly evolving AI partnership ecosystem, which will prove positive to long-term growth, RBC added.

Valuation Metrics

The current forward P/E ratio for Accenture PLC (ACN.N) is 18.62, compared to its 5-year average forward P/E of 26.56. For a more detailed relative valuation and DCF analysis to assess Accenture PLC 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

26.56

Current PE

18.62

Overvalued PE

30.85

Undervalued PE

22.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

15.70

Current EV/EBITDA

9.44

Overvalued EV/EBITDA

18.04

Undervalued EV/EBITDA

13.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.01

Current PS

2.14

Overvalued PS

3.46

Undervalued PS

2.56

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress areSelling! The selling amount has increased332.1%over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ACN News & Events

Events Timeline

No data

News

4.5

18:04 PMNASDAQ.COM

SPHQ ETF Hits 52-Week High of $77.31 Amid Trading Insights

7.5

17:32 PMGlobenewswire

Quantum Secure Encryption Corp Expands Global Footprint, Enters Indonesian Market

5.0

01-07Globenewswire

Acronis Appoints Jo Holliday as UKI General Manager to Drive Regional Growth

People Also Watch

Frequently Asked Questions

What is Accenture PLC (ACN) stock price today?

The current price of ACN is 281.82 USD — it has increased 2.86 % in the last trading day.

What is Accenture PLC (ACN)'s business?

Accenture plc is a global professional services company. It is engaged in providing a range of services and solutions across strategy and consulting, technology, operations, Industry X and Song. Its services include application services, artificial intelligence, automation, business process outsourcing, business strategy, change management, cloud, customer experience, data and analytics, ecosystem partners, finance consulting, Industry X, infrastructure, marketing, mergers and acquisitions, operating models, security, supply chain management, sustainability, technology consulting, technology innovation, and zero-based budgeting (ZBB). It specializes in the SAP business technology platform that designs digital products and experiences for enterprise customers, including custom portals and Web solutions and mobile applications. It provides clients with quantitative and qualitative risk management and compliance services. It specializes in advisory, management services and cybersecurity.

What is the price predicton of ACN Stock?

What is Accenture PLC (ACN)'s revenue for the last quarter?

Accenture PLC revenue for the last quarter amounts to 18.74B USD, increased 5.95 % YoY.

What is Accenture PLC (ACN)'s earnings per share (EPS) for the last quarter?

Accenture PLC. EPS for the last quarter amounts to 3.54 USD, decreased -1.39 % YoY.

What changes have occurred in the market's expectations for Accenture PLC (ACN)'s fundamentals?

How many employees does Accenture PLC (ACN). have?

Accenture PLC (ACN) has 779000 emplpoyees as of January 08 2026.

What is Accenture PLC (ACN) market cap?

Today ACN has the market capitalization of 186.18B USD.